| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.31 | 4e-05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 0.0001 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |